EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Vaccine


 

Status
active
Indexing
ADONIS; AIDS; AIDS Information; Abstracts on Hygiene and Communicable Diseases; BIOSIS; Biotechnology Abstracts; Chemical Abstracts; Current AIDS Literature; Current Contents; Current Opinion in Immunology; Current Opinion in Infectious Diseases; EMBASE; Elsevier BIOBASE; Focus on: Veterinary Science and Medicine; Index Veterinarius; MEDLINE®; SIIC-Data bases; Scopus; Telegen; Tropical Diseases Bulletin; Veterinary Bulletin; Virus Information Exchange Newsletter
Subject

Source type
Journal
Publisher
ISBN ISSN
0264-410X
First volume
1
Last volume
25+
Homepage
Description
VACCINE is the pre-eminent journal for those interested in vaccines and vaccination. It serves as an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic research through to applications, safety and legislation.

Key aspects include
• human • veterinary • disease prevention
• physiological manipulation • molecular biology • synthetic peptides
• recombinant antigens • vectors • new immunogens
• adjuvants • animal models • immunity
• immunology of protection • fertility • academic research
• developmental applications • field trials • clinical trials
• laboratory productions • industrial production • social implications
• epidemiology • efficacy • safety
• legislation • regulation • cost/benefit

These aspects may be applied to diseases caused by: viruses, bacteria, mycoplasma, protozoa, fungi, helminths, arthropods,prions











Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )